gp100 antigen; tyrosinase peptide; recombinant MAGE-3.1 antigen; multi-epitope melanoma peptide vaccine; incomplete Freund's adjuvant; montanide ISA 51 VG; agatolimod sodium. This evidence concerns the gene TYR and melanoma.